Please login to the form below
personalised medicine
This page shows the latest personalised medicine news and features for those working in and with pharma, biotech and healthcare.
NICE plans to widen the net for data it uses in guidance
That update is intended to take into account developments such as personalised medicine, digitisation of health and use of cell and gene therapy.
Latest news
-
Immuno-oncology, personalised medicine continues to drive pharma sector
or personalised medicine as the most significant trends that will shape the pharma sector this year. ... Last November, GlobalData identified personalised medicine as a key improvement in the treatment pathway, but said that gaining access to these
-
AZ, Merck’s Lynparza narrowly scores FDA approval for pancreatic cancer
We are pleased with the ODAC’s recommendation for Lynparza and the potential to bring a personalised, biomarker-targeted medicine to patients with germline BRCA-mutated metastatic pancreatic cancer,” said José
-
Four digital health trends set to reinvent and re-energise pharma
For example, Abilify MyCite is the first ‘digital medicine’ approved by the FDA in the US. ... This is a fine illustration of the new era of personalised medicine – and the advantages aren’t just for the small number of patients in the pilot
-
Personalised medicine can improve treatment, but access still an issue
By identifying patient subgroups through biomarker analysis, personalised medicine will help identify which groups may benefit from a given treatment,” said Michael Breen, associate director at GlobalData. ... GlobalData's report also highlights that
-
NICE unveils long-awaited review of methodologies
He added: “NICE is undertaking this review at a time of unprecedented change in the healthcare system, where developments such as personalised medicine, digitalisation of health, and use of cell and
More from news
Approximately 12 fully matching, plus 108 partially matching documents found.
Latest Intelligence
-
Emerging use cases of blockchain in healthcare and the life sciences
Additional implementations can be found within prescription medicine management, patient claims and billings management, and data security for wearables and other IoT medical devices, as well as deployment in personalised medicine.
-
Biopharma and orphan drugs
It’s important to highlight that advances in personalised medicine have additional regulatory requirements, such as biomarker validation. ... She cited parallel studies as an example, explaining the ability to investigate the effect of a new medicine
-
Delivering the promise of regenerative medicine
The cutting-edge innovations of regenerative medicine generally fall into three distinct categories:. ... Regenerative medicine is either personalised or matched to the donor-recipient. They are also highly sensitive to exogenous factors like time and
-
Evolution or revolution: the latest review of NICE methods
These include personalised medicine, digitalisation of health, and cell and gene therapies.
-
Changing direction: adapting to a rapidly-evolving environment
When you marry this up with advances such as personalised medicine and nanotechnology, it’s easy to see how technology could finally help us deliver on the promise that prevention is ... on its own. Fulfilling the promise of predictive technology and
More from intelligence
Approximately 4 fully matching, plus 32 partially matching documents found.
Latest appointments
-
BMS appoints new commercial leader, Davies joins Eisai and more
The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”.
-
Stephen Eck joins Aravive Biologics
chairman of the board of directors of the Personalised Medicine Coalition.
-
FlowMetric Diagnostics names president
It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and
-
GlobalData makes Americas appointment
Dr Bonnie Bain, global head of healthcare at GlobalData, adds: “Sean is widely recognised as an expert and thought leader in personalised and translational medicine, and it's great to welcome
-
Roche appoints new oncology research head
Personalised cancer has been his forte, however, and he has served as director of personalised cancer medicine at Vanderbilt. ... I was particularly attracted to Roche as one of the pioneers and front-runners in personalised medicine, as the world's top
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
In the precision medicine era, the line between products and services is blurred
Personalised and precision medicine, however, can offer specialised treatments that target the patient’s unique cancer subtype, its genetic mutations, and the affected tissues. ... Optimising the service behind the personalised and precision medicine
-
Making a difference with patient support
Empowering the patient. Providing a stepping-stone to personalised medicine. Reassuring HCPs that the treatment is a both viable option for the patient and that it is adequately supported.
-
Perspective: the patient edition
The ALS patient journey. An article on CAR-T service design. Thought provoking content on clinical trial access and the social determinants of healthcare, and on precision and personalised medicine.
-
Spotlight interview: 15 minutes on Independent Medical Education
By looking at futuristic things that are already impacting healthcare for example artificial intelligence, and personalised medicine, , we have a real opportunity for IME to make an impact on both medical ... There will be many more “small group” or
-
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can ... Innovative pricing models in precision and
More from PMHub
Approximately 4 fully matching, plus 26 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19
- BMS eyes approval for second Opdivo combo in kidney cancer
- FDA hands BMS and bluebird bio a priority review for ide-cel
- 20 for 2020 – Five pharma companies to watch
- Using Artificial Intelligence to Transform Pharma
- Session 4: Systems Innovation Insight and Thinking
- Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- Keytruda doubles five-year survival rate in NSCLC
- EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
